[Federal Register Volume 64, Number 123 (Monday, June 28, 1999)]
[Notices]
[Page 34681]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-16262]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Registration
By Notice dated March 1, 1999, and published in the Federal
Register on April 1, 1999, (64 FR 15808), Lilly Del Caribe, Inc.,
Chemical Plant, Kilometer 146.7, State Road 2, Mayaguez, Puerto Rico
00680, made application by renewal to the Drug Enforcement
Administration (DEA) to be registered as a bulk manufacturer of
dextropropoxyphene (9273), a basic class of controlled substance listed
in Schedule II.
The firm plans to manufacture bulk product for distribution to its
customers.
DEA has considered the factors in Title 21, United States Code,
Section 823(a) and determined that the registration of Lilly Del
Caribe, Inc. to manufacture dextropropoxyphene is consistent with the
public interest at this time. DEA has investigated Lilly Del Caribe,
Inc. on a regular basis to ensure that the company's continued
registration is consistent with the public interest. These
investigations have included inspection and testing of the company's
physical security systems, audits of the company's records,
verification of the company's compliance with state and local laws, and
a review of the company's background and history. Therefore, pursuant
to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the Deputy Assistant
Administrator, Office of Diversion Control, hereby orders that the
application submitted by the above firm for registration as a bulk
manufacturer of the basic class of controlled substance listed above is
granted.
Dated: June 15, 1999.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 99-16262 Filed 6-25-99; 8:45 am]
BILLING CODE 4410-09-M
